LOW FLAT RATE $9.90 AUST-WIDE DELIVERY

Close Notification

Your cart does not contain any items

$70.95

Paperback

Not in-store but you can order this
How long will it take?

QTY:

English
Wiley-Blackwell
26 April 2017
Pharmacovigilance is the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problems.

This introductory guide is designed to aid the rapid understanding of the key principles of pharmacovigilance. Packed full of examples illustrating drug safety issues it not only covers the processes involved, but the regulatory aspects and ethical and societal considerations of pharmacovigilance.

Covering the basics step-by-step, this book is perfect for beginners and is essential reading for those new to drug safety departments and pharmaceutical medicine students. The second edition is thoroughly revised and updated throughout and includes a new chapter on clinical aspects of pharmacovigilance.
By:   ,
Imprint:   Wiley-Blackwell
Country of Publication:   United Kingdom
Edition:   2nd edition
Dimensions:   Height: 216mm,  Width: 140mm,  Spine: 10mm
Weight:   272g
ISBN:   9781119289746
ISBN 10:   1119289742
Pages:   192
Publication Date:  
Audience:   Professional and scholarly ,  Undergraduate
Format:   Paperback
Publisher's Status:   Active
Foreword ix Preface to the Second Edition xi Preface to the First Edition xiii Acknowledgements xv List of Abbreviations xvii 1 What is Pharmacovigilance and How Has it Developed? 1 2 Basic Concepts 19 3 Types and Sources of Data 37 4 The Process of Pharmacovigilance 55 5 Regulatory Aspects of Pharmacovigilance 75 6 International Collaboration 95 7 Clinical Aspects of Adverse Drug Reactions 109 8 Ethical and Societal Considerations 123 9 Future Directions 135 10 Learning More About Pharmacovigilance 145 Glossary 151 Index 157

Patrick Waller MD, MPH, FRCPEd, FFPM, Formerly Honorary Professor, London School of Hygiene and Tropical Medicine, London, United Kingdom. Mira Harrison-Woolrych BM, DM, DFFP, FRCOG, Honorary Research Associate Professor, Dunedin School of Medicine, University of Otago, New Zealand; Senior Medical Assessor, Vigilance and Risk Management, Medicines and Healthcare products Regulatory Agency (MHRA), London, UK and Secretary General of the International Society of Pharmacovigilance (ISoP).

See Also